IMM 4.41% 35.5¢ immutep limited

re-read phase 2a results of all terminally ill, page-20

  1. 864 Posts.
    lightbulb Created with Sketch. 28
    Goggo you are spot in writing "Apart from the data that has been gathered from the Phase 2a and Phase 2b PRR trials, it seems likely to me that other Medical practitioners/patients may have availed themselves of the "Special Access Scheme" to enter PRR treatment.

    If this is the case, there may be much more data available to PRR (albeit not statistically compliant) which has contributed to their confidence in going forward with the large-scale global CANVAS Phase 111 trial."

    I believe that's why Neil Frazer said "we know it works. We only have to prove it".
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.015(4.41%)
Mkt cap ! $515.6M
Open High Low Value Volume
34.0¢ 36.0¢ 34.0¢ $1.270M 3.611M

Buyers (Bids)

No. Vol. Price($)
7 286261 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 253490 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.